Showing results (21-30 of 199) with videos related to

Sort By:
Pageof 20
Clinical and Experimental Rheumatology|November 18, 2015
CTLA-4 Ig as an effective treatment in a patient with type I diabetes mellitus and seropositive rheumatoid arthritisAnna Laura Fedele, Stefano Alivernini, Elisa Gremese, et al.
Autoimmunity Reviews|April 13, 2005
TNF-alpha, rheumatoid arthritis, and heart failure: a rheumatological dilemmaPiercarlo Sarzi-Puttini, Fabiola Atzeni, Yehuda Shoenfeld, et al.
Modern Rheumatology|May 7, 2020
Comprehensive review on intravertebral intraspinal, intrajoint, and intradiscal vacuum phenomenon: From anatomy and physiology to pathologyFrancesco Cianci, Gianfranco Ferraccioli, Edoardo Sean Ferraccioli, et al.
Clinical Immunology (Orlando, Fla.)|April 3, 2020
Checkpoint inhibitors (CPI) and autoimmune chronic inflammatory diseases (ACIDs): tolerance and loss of tolerance in the occurrence of immuno-rheumatologic manifestationsElisa Gremese, Stefano Alivernini, Edoardo Sean Ferraccioli, et al.
Reumatismo|April 28, 2006
[Migraine in SLE: role of antiphospholipid antibodies and Raynaud's phenomenon]Virginia Annese, Paola Tomietto, Paolo Venturini, et al.
Frontiers in Medicine|October 31, 2025
Autoimmune inflammation as a key risk factor for heart failure with preserved ejection fraction: the different types of inflammation driving to HFpEFElisa Gremese, Dario Bruno, Simone Perniola, et al.
Arthritis Research & Therapy|November 6, 2009
ACR70-disease activity score remission achievement from switches between all the available biological agents in rheumatoid arthritis: a systematic review of the literatureStefano Alivernini, Antonella Laria, Elisa Gremese, et al.
Rheumatology (Oxford, England)|June 22, 2012
Optimizing outcomes in rheumatoid arthritis patients with inadequate responses to disease-modifying anti-rheumatic drugsKarel Pavelka, Arthur F Kavanaugh, Andrea Rubbert-Roth, et al.
Medicine|June 15, 2017
Refractory adult-onset Still disease complicated by macrophage activation syndrome and acute myocarditis: A case report treated with high doses (8 mg/kg/d) of anakinraFederico Parisi, Annamaria Paglionico, Valentina Varriano, et al.
Autoimmunity Reviews|April 22, 2022
Infectious agents breaking the immunological tolerance: The holy grail in rheumatoid arthritis reconsideredElisa Gremese, Barbara Tolusso, Dario Bruno, et al.
Pageof 20